Discovery of a Novel COS/H2S-Donor Hybridized sGC Stimulator for Alleviating Isoproterenol-Induced Myocardial Fibrosis
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c02191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yi Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Soluble Guanylyl Cyclase, Myocardium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Myocardial fibrosis contributes to heart failure (HF) progression, which is associated with impaired nitric oxide (NO)–soluble guanylyl cyclase (sGC)–cyclic guanosine monophosphate (cGMP) signaling. Hydrogen sulfide (H2S), a cardioprotective gasotransmitter, is reduced in patients with HF. Therapeutic options targeting both sGC activation and H2S enhancement remain limited. We have developed a novel carbonyl sulfide (COS)/H2S-donor hybrid sGC stimulator, COS-A, which exhibits a well-characterized H2S-releasing property. Compound COS-A outperformed vericiguat in sGC activation in vitro and reduced fibrosis in transforming growth factor-beta 1 (TGF-β1)-treated cardiac fibroblasts by increasing cGMP and H2S levels. In isoproterenol (ISO)-induced HF mice, COS-A improved cardiac function comparably to vericiguat. Histological findings revealed its antifibrotic effects through sGC activation and elevation of H2S. Our findings indicate that this COS/H2S-donor hybridized sGC stimulator holds therapeutic promise for HF treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
- School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
- Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
- Sun Yat-sen University Nanchang Research Institute, Nanchang 330096, China.
ORCID-Profile: Lei Guo
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Yang, Y., Wu, J., He, G., Yao, S., Wei, L. Y., Wang, Q., Dai, W., Yuan, H., Chen, J., Wang, X., & Guo, L. (2025). Discovery of a Novel COS/H2S-Donor Hybridized sGC Stimulator for Alleviating Isoproterenol-Induced Myocardial Fibrosis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02191
Vancouver
Yang Y, Wu J, He G, Yao S, Wei LY, Wang Q, et al. Discovery of a Novel COS/H2S-Donor Hybridized sGC Stimulator for Alleviating Isoproterenol-Induced Myocardial Fibrosis. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02191
BibTeX
@article{Yang2025,
author = {Yang, Yi and Wu, Jiafei and He, Gongyun and Yao, Siqi and Wei, Li-Yuan and Wang, Quan and Dai, Wei and Yuan, Han and Chen, Jianwen and Wang, Xiaoying and Guo, Lei},
title = {Discovery of a Novel COS/H2S-Donor Hybridized sGC Stimulator for Alleviating Isoproterenol-Induced Myocardial Fibrosis},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c02191}
}
EUVIMED